{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,23]],"date-time":"2024-07-23T05:14:40Z","timestamp":1721711680755},"reference-count":72,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2013,1,15]],"date-time":"2013-01-15T00:00:00Z","timestamp":1358208000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0054434","type":"journal-article","created":{"date-parts":[[2013,1,15]],"date-time":"2013-01-15T22:24:17Z","timestamp":1358288657000},"page":"e54434","update-policy":"http:\/\/dx.doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":16,"title":["Immunogenicity of Seven New Recombinant Yellow Fever Viruses 17D Expressing Fragments of SIVmac239 Gag, Nef, and Vif in Indian Rhesus Macaques"],"prefix":"10.1371","volume":"8","author":[{"given":"Mauricio A.","family":"Martins","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Myrna C.","family":"Bonaldo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard A.","family":"Rudersdorf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shari M.","family":"Piaskowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva G.","family":"Rakasz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kim L.","family":"Weisgrau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica R.","family":"Furlott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher M.","family":"Eernisse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marlon G.","family":"Veloso de Santana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bertha","family":"Hidalgo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas C.","family":"Friedrich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria J.","family":"Chiuchiolo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher L.","family":"Parks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nancy A.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David B.","family":"Allison","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ricardo","family":"Galler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David I.","family":"Watkins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2013,1,15]]},"reference":[{"key":"ref1","first-page":"250","article-title":"Pneumocystis pneumonia\u2013Los Angeles","volume":"30","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref2","unstructured":"HIV\/AIDS JUNPo (2010) Global report: UNAIDS report on the global AIDS pandemic 2010."},{"key":"ref3","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.immuni.2010.09.011","article-title":"Induction of immunity to human immunodeficiency virus type-1 by vaccination","volume":"33","author":"MJ McElrath","year":"2010","journal-title":"Immunity"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"13239","DOI":"10.1128\/JVI.79.21.13239-13249.2005","article-title":"Selective escape from CD8+ T-cell responses represents a major driving force of human immunodeficiency virus type 1 (HIV-1) sequence diversity and reveals constraints on HIV-1 evolution","volume":"79","author":"TM Allen","year":"2005","journal-title":"J Virol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1146\/annurev.med.54.101601.152346","article-title":"The influence of HLA genotype on AIDS","volume":"54","author":"M Carrington","year":"2003","journal-title":"Annu Rev Med"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"3465","DOI":"10.1128\/JVI.02392-06","article-title":"Subdominant CD8+ T-cell responses are involved in durable control of AIDS virus replication","volume":"81","author":"TC Friedrich","year":"2007","journal-title":"J Virol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1038\/nri2357","article-title":"Impact of MHC class I diversity on immune control of immunodeficiency virus replication","volume":"8","author":"PJ Goulder","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1084\/jem.189.6.991","article-title":"Dramatic rise in plasma viremia after CD8(+) T cell depletion in simian immunodeficiency virus-infected macaques","volume":"189","author":"X Jin","year":"1999","journal-title":"J Exp Med"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1128\/JVI.72.1.164-169.1998","article-title":"Administration of an anti-CD8 monoclonal antibody interferes with the clearance of chimeric simian\/human immunodeficiency virus during primary infections of rhesus macaques","volume":"72","author":"T Matano","year":"1998","journal-title":"J Virol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1126\/science.1195271","article-title":"The major genetic determinants of HIV-1 control affect HLA class I peptide presentation","volume":"330","author":"F Pereyra","year":"2010","journal-title":"Science"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"6376","DOI":"10.4049\/jimmunol.169.11.6376","article-title":"Presence of HIV-1 Gag-specific IFN-gamma+IL-2+ and CD28+IL-2+ CD4 T cell responses is associated with nonprogression in HIV-1 infection","volume":"169","author":"MJ Boaz","year":"2002","journal-title":"J Immunol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1128\/JVI.01816-07","article-title":"The major histocompatibility complex class II alleles Mamu-DRB1*1003 and -DRB1*0306 are enriched in a cohort of simian immunodeficiency virus-infected rhesus macaque elite controllers","volume":"82","author":"JP Giraldo-Vela","year":"2008","journal-title":"J Virol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1126\/science.278.5342.1447","article-title":"Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia","volume":"278","author":"ES Rosenberg","year":"1997","journal-title":"Science"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"2746","DOI":"10.4049\/jimmunol.178.5.2746","article-title":"Gag-specific CD8+ T lymphocytes recognize infected cells before AIDS-virus integration and viral protein expression","volume":"178","author":"JB Sacha","year":"2007","journal-title":"J Immunol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.immuni.2010.10.004","article-title":"Immunologic basis of vaccine vectors","volume":"33","author":"MA Liu","year":"2010","journal-title":"Immunity"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1097\/COH.0b013e32833cfe4c","article-title":"Novel adenovirus vector-based vaccines for HIV-1","volume":"5","author":"DH Barouch","year":"2010","journal-title":"Curr Opin HIV AIDS"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1097\/COH.0b013e32833d1e87","article-title":"Poxvirus vector-based HIV vaccines","volume":"5","author":"G Pantaleo","year":"2010","journal-title":"Curr Opin HIV AIDS"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.copbio.2007.10.010","article-title":"Replicating and non-replicating viral vectors for vaccine development","volume":"18","author":"M Robert-Guroff","year":"2007","journal-title":"Curr Opin Biotechnol"},{"key":"ref19","first-page":"4654","article-title":"Comparative seroprevalence and immunogenicity of six rare serotype recombinant adenovirus vaccine vectors from subgroups B and D. J Virol","volume":"81","author":"P Abbink","year":"2007"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1016\/S0140-6736(08)61591-3","article-title":"Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial","volume":"372","author":"SP Buchbinder","year":"2008","journal-title":"Lancet"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1016\/S0140-6736(08)61592-5","article-title":"HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case-cohort analysis","volume":"372","author":"MJ McElrath","year":"2008","journal-title":"Lancet"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"3781","DOI":"10.1128\/JCM.01249-06","article-title":"Age dependence of adenovirus-specific neutralizing antibody titers in individuals from sub-Saharan Africa","volume":"44","author":"AR Thorner","year":"2006","journal-title":"J Clin Microbiol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1099\/vir.0.82493-0","article-title":"Clinical experience with plasmid DNA- and modified vaccinia virus Ankara-vectored human immunodeficiency virus type 1 clade A vaccine focusing on T-cell induction","volume":"88","author":"T Hanke","year":"2007","journal-title":"J Gen Virol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1086\/422258","article-title":"Safety and immunogenicity of an HIV subtype B and E prime-boost vaccine combination in HIV-negative Thai adults","volume":"190","author":"S Nitayaphan","year":"2004","journal-title":"J Infect Dis"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/01.qai.0000248356.48501.ff","article-title":"Phase 2 study of an HIV-1 canarypox vaccine (vCP1452) alone and in combination with rgp120: negative results fail to trigger a phase 3 correlates trial","volume":"44","author":"ND Russell","year":"2007","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.coi.2009.05.018","article-title":"Yellow fever vaccine - how does it work and why do rare cases of serious adverse events take place?","volume":"21","author":"AD Barrett","year":"2009","journal-title":"Curr Opin Immunol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1586\/14760584.4.4.553","article-title":"Yellow fever vaccine","volume":"4","author":"TP Monath","year":"2005","journal-title":"Expert Rev Vaccines"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/nri2629","article-title":"Learning immunology from the yellow fever vaccine: innate immunity to systems vaccinology","volume":"9","author":"B Pulendran","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1084\/jem.20051720","article-title":"Yellow fever vaccine YF-17D activates multiple dendritic cell subsets via TLR2, 7, 8, and 9 to stimulate polyvalent immunity","volume":"203","author":"T Querec","year":"2006","journal-title":"J Exp Med"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/978-0-387-34814-8_3","article-title":"Understanding the role of innate immunity in the mechanism of action of the live attenuated Yellow Fever Vaccine 17D","volume":"590","author":"TD Querec","year":"2007","journal-title":"Adv Exp Med Biol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1086\/511869","article-title":"Yellow fever: epidemiology and prevention","volume":"44","author":"ED Barnett","year":"2007","journal-title":"Clin Infect Dis"},{"key":"ref32","unstructured":"Organization WH (2009) WHO Vaccine-preventable diseases: monitoring system."},{"key":"ref33","doi-asserted-by":"crossref","first-page":"12497","DOI":"10.1128\/JVI.78.22.12497-12507.2004","article-title":"ChimeriVax-West Nile virus live-attenuated vaccine: preclinical evaluation of safety, immunogenicity, and efficacy","volume":"78","author":"J Arroyo","year":"2004","journal-title":"J Virol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1006\/jmbi.2001.5258","article-title":"Surface expression of an immunodominant malaria protein B cell epitope by yellow fever virus","volume":"315","author":"MC Bonaldo","year":"2002","journal-title":"J Mol Biol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"9197","DOI":"10.1128\/JVI.74.19.9197-9205.2000","article-title":"Recombinant yellow fever viruses are effective therapeutic vaccines for treatment of murine experimental solid tumors and pulmonary metastases","volume":"74","author":"A McAllister","year":"2000","journal-title":"J Virol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/1743-422X-4-115","article-title":"Construction and characterization of recombinant flaviviruses bearing insertions between E and NS1 genes","volume":"4","author":"MC Bonaldo","year":"2007","journal-title":"Virol J"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"3699","DOI":"10.1128\/JVI.02255-09","article-title":"Recombinant yellow fever vaccine virus 17D expressing simian immunodeficiency virus SIVmac239 gag induces SIV-specific CD8+ T-cell responses in rhesus macaques","volume":"84","author":"MC Bonaldo","year":"2010","journal-title":"J Virol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"4352","DOI":"10.1128\/JVI.02365-09","article-title":"T-cell correlates of vaccine efficacy after a heterologous simian immunodeficiency virus challenge","volume":"84","author":"MA Martins","year":"2010","journal-title":"J Virol"},{"key":"ref39","unstructured":"Weatherall D (2006) The use of non-human primates in research: A working group report. Final Report December 2006. FRS FMedSci."},{"key":"ref40","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1007\/s00251-007-0233-7","article-title":"Molecular typing of major histocompatibility complex class I alleles in the Indian rhesus macaque which restrict SIV CD8+ T cell epitopes","volume":"59","author":"M Kaizu","year":"2007","journal-title":"Immunogenetics"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"8827","DOI":"10.1128\/JVI.00895-07","article-title":"Mamu-B*08-positive macaques control simian immunodeficiency virus replication","volume":"81","author":"JT Loffredo","year":"2007","journal-title":"J Virol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0168-1702(01)00273-8","article-title":"Construction, characterization and immunogenicity of recombinant yellow fever 17D-dengue type 2 viruses","volume":"79","author":"PS Caufour","year":"2001","journal-title":"Virus Res"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1600-0684.2005.00128.x","article-title":"Highly sensitive SIV plasma viral load assay: practical considerations, realistic performance expectations, and application to reverse engineering of vaccines for AIDS","volume":"34","author":"AN Cline","year":"2005","journal-title":"J Med Primatol"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"9578","DOI":"10.1128\/JVI.05060-11","article-title":"Enhanced control of pathogenic Simian immunodeficiency virus SIVmac239 replication in macaques immunized with an interleukin-12 plasmid and a DNA prime-viral vector boost vaccine regimen","volume":"85","author":"N Winstone","year":"2011","journal-title":"J Virol"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"7498","DOI":"10.1128\/JVI.70.11.7498-7509.1996","article-title":"Evaluation of the concentration and bioactivity of adenovirus vectors for gene therapy","volume":"70","author":"N Mittereder","year":"1996","journal-title":"J Virol"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/cyto.a.21015","article-title":"SPICE: exploration and analysis of post-cytometric complex multivariate datasets","volume":"79","author":"M Roederer","year":"2011","journal-title":"Cytometry A"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"2582","DOI":"10.1016\/j.vaccine.2011.01.049","article-title":"HIV fragment gag vaccine induces broader T cell response in mice","volume":"29","author":"Y Liu","year":"2011","journal-title":"Vaccine"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"4251","DOI":"10.1128\/JVI.76.9.4251-4259.2002","article-title":"Immunodominance in virus-induced CD8(+) T-cell responses is dramatically modified by DNA immunization and is regulated by gamma interferon","volume":"76","author":"F Rodriguez","year":"2002","journal-title":"J Virol"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"e1002041","DOI":"10.1371\/journal.ppat.1002041","article-title":"Protective efficacy of serially up-ranked subdominant CD8+ T cell epitopes against virus challenges","volume":"7","author":"EJ Im","year":"2011","journal-title":"PLoS Pathog"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"5064","DOI":"10.4049\/jimmunol.173.8.5064","article-title":"Identification of seventeen new simian immunodeficiency virus-derived CD8+ T cell epitopes restricted by the high frequency molecule, Mamu-A*02, and potential escape from CTL recognition","volume":"173","author":"JT Loffredo","year":"2004","journal-title":"J Immunol"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"11623","DOI":"10.1128\/JVI.76.22.11623-11636.2002","article-title":"Escape in one of two cytotoxic T-lymphocyte epitopes bound by a high-frequency major histocompatibility complex class I molecule, Mamu-A*02: a paradigm for virus evolution and persistence?","volume":"76","author":"TU Vogel","year":"2002","journal-title":"J Virol"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"5212","DOI":"10.1016\/j.vaccine.2005.07.086","article-title":"A computational resource for the prediction of peptide binding to Indian rhesus macaque MHC class I molecules","volume":"23","author":"B Peters","year":"2005","journal-title":"Vaccine"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"8183","DOI":"10.1016\/j.vaccine.2010.09.090","article-title":"CD8+ gamma-delta TCR+ and CD4+ T cells produce IFN-gamma at 5\u20137 days after yellow fever vaccination in Indian rhesus macaques, before the induction of classical antigen-specific T cell responses","volume":"28","author":"PC Neves","year":"2010","journal-title":"Vaccine"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/35036559","article-title":"Tat-specific cytotoxic T lymphocytes select for SIV escape variants during resolution of primary viraemia","volume":"407","author":"TM Allen","year":"2000","journal-title":"Nature"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1128\/JVI.76.2.875-884.2002","article-title":"Dominance of CD8 responses specific for epitopes bound by a single major histocompatibility complex class I molecule during the acute phase of viral infection","volume":"76","author":"BR Mothe","year":"2002","journal-title":"J Virol"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"4781","DOI":"10.1182\/blood-2005-12-4818","article-title":"HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells","volume":"107","author":"MR Betts","year":"2006","journal-title":"Blood"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1586\/erv.10.139","article-title":"IMOJEV((R)): a Yellow fever virus-based novel Japanese encephalitis vaccine","volume":"9","author":"MB Appaiahgari","year":"2010","journal-title":"Expert Rev Vaccines"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1385\/CBB:44:3:313","article-title":"Expression of foreign protein epitopes at the surface of recombinant yellow fever 17D viruses based on three-dimensional modeling of its envelope protein","volume":"44","author":"MC Bonaldo","year":"2006","journal-title":"Cell Biochem Biophys"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"4761","DOI":"10.1128\/JVI.78.9.4761-4775.2004","article-title":"Safety and efficacy of chimeric yellow Fever-dengue virus tetravalent vaccine formulations in nonhuman primates","volume":"78","author":"F Guirakhoo","year":"2004","journal-title":"J Virol"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"5712","DOI":"10.1016\/j.vaccine.2008.08.019","article-title":"Cell-mediated immunity induced by chimeric tetravalent dengue vaccine in naive or flavivirus-primed subjects","volume":"26","author":"B Guy","year":"2008","journal-title":"Vaccine"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.vaccine.2009.09.098","article-title":"Preclinical and clinical development of YFV 17D-based chimeric vaccines against dengue, West Nile and Japanese encephalitis viruses","volume":"28","author":"B Guy","year":"2010","journal-title":"Vaccine"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"7229","DOI":"10.1016\/j.vaccine.2011.06.094","article-title":"From research to phase III: preclinical, industrial and clinical development of the Sanofi Pasteur tetravalent dengue vaccine","volume":"29","author":"B Guy","year":"2011","journal-title":"Vaccine"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1086\/378356","article-title":"Chimeric live, attenuated vaccine against Japanese encephalitis (ChimeriVax-JE): phase 2 clinical trials for safety and immunogenicity, effect of vaccine dose and schedule, and memory response to challenge with inactivated Japanese encephalitis antigen","volume":"188","author":"TP Monath","year":"2003","journal-title":"J Infect Dis"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"6694","DOI":"10.1073\/pnas.0601932103","article-title":"A live, attenuated recombinant West Nile virus vaccine","volume":"103","author":"TP Monath","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1093\/infdis\/jiq074","article-title":"Development of antigen-specific memory CD8+ T cells following live-attenuated chimeric West Nile virus vaccination","volume":"203","author":"HL Smith","year":"2011","journal-title":"J Infect Dis"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1084\/jem.20041526","article-title":"Yellow fever 17D as a vaccine vector for microbial CTL epitopes: protection in a rodent malaria model","volume":"201","author":"D Tao","year":"2005","journal-title":"J Exp Med"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"5676","DOI":"10.1016\/j.vaccine.2010.06.052","article-title":"Evaluation of yellow fever virus 17D strain as a new vector for HIV-1 vaccine development","volume":"28","author":"D Franco","year":"2010","journal-title":"Vaccine"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.1128\/jvi.76.5.2298-2305.2002","article-title":"Magnitude of functional CD8+ T-cell responses to the gag protein of human immunodeficiency virus type 1 correlates inversely with viral load in plasma","volume":"76","author":"BH Edwards","year":"2002","journal-title":"J Virol"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/nm1520","article-title":"CD8+ T-cell responses to different HIV proteins have discordant associations with viral load","volume":"13","author":"P Kiepiela","year":"2007","journal-title":"Nat Med"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"e1424","DOI":"10.1371\/journal.pone.0001424","article-title":"Broad and Gag-biased HIV-1 epitope repertoires are associated with lower viral loads","volume":"3","author":"M Rolland","year":"2008","journal-title":"PLoS One"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"11991","DOI":"10.1128\/JVI.01348-06","article-title":"Modulation of DNA vaccine-elicited CD8+ T-lymphocyte epitope immunodominance hierarchies","volume":"80","author":"J Liu","year":"2006","journal-title":"J Virol"},{"key":"ref72","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1590\/S0074-02762005000300021","article-title":"Lymphocyte subset analyses in healthy adults vaccinated with yellow fever 17DD virus","volume":"100","author":"AP Santos","year":"2005","journal-title":"Mem Inst Oswaldo Cruz"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0054434","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,20]],"date-time":"2020-07-20T12:41:24Z","timestamp":1595248884000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0054434"}},"subtitle":[],"editor":[{"given":"Clive M.","family":"Gray","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2013,1,15]]},"references-count":72,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2013,1,15]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0054434","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,1,15]]}}}